📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
TAKE Solutions Approves Shifting Registered Office and Appoints New Statutory Auditors
TAKE Solutions held an Extraordinary General Meeting (EOGM) on March 7, 2026, to approve several key governance and strategic changes. Shareholders voted to regularize the appointments of two Non-Executive Directors and approved M/s. Venkat and Rangaa LLP as the new Statutory Auditors following a casual vacancy. A significant special resolution was passed to shift the company's Registered Office from Tamil Nadu to Maharashtra. These moves coincide with the company's stated strategic transformation toward AI-driven healthcare and scalable technology platforms.
Key Highlights
Approved the appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors following the resignation of M/s. Sundar Srini & Sridhar.
Passed a special resolution to shift the Registered Office from Tamil Nadu to Maharashtra.
Regularized the appointments of Mr. Parmeshvar Dhangare and Mr. Vilas Munis as Non-Executive Directors.
Company reported a total of 66,526 members as of the February 28, 2026, cut-off date.
Management highlighted a strategic pivot toward AI-driven healthcare, diagnostics, and preventive care.
💼 Action for Investors
Investors should monitor the transition to the new statutory auditors and the relocation to Maharashtra for any operational disruptions. The strategic shift toward AI-driven healthcare is a long-term play that requires tracking for actual revenue execution.
TAKE Solutions EOGM: Shifting Office to Maharashtra and New Auditor Appointment
TAKE Solutions held an Extra Ordinary General Meeting on March 7, 2026, to approve several key governance and operational changes. Shareholders voted on the regularization of two Non-Executive Directors and the appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors following a casual vacancy. A significant special resolution was proposed to shift the company's registered office from Tamil Nadu to Maharashtra. The management also emphasized a strategic pivot toward AI-driven healthcare and diagnostics platforms.
Key Highlights
Approval for shifting the Registered Office from Tamil Nadu to Maharashtra via a Special Resolution.
Appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors to fill the vacancy caused by the resignation of M/s. Sundar Srini & Sridhar.
Regularization of Mr. Parmeshvar Dhangare and Mr. Vilas Munis as Non-Executive Non-Independent Directors.
The meeting was attended by 38 members out of a total shareholder base of 66,526 as of February 28, 2026.
Strategic focus reaffirmed on building scalable technology-led platforms in AI-driven healthcare and preventive care.
💼 Action for Investors
Investors should monitor the transition to the new registered office and any further disclosures regarding the auditor's resignation. The company's shift toward AI-driven healthcare is a long-term strategic move that requires tracking for execution milestones.
TAKE Solutions Integrates Anthropic's Claude AI to Target $370B Healthcare Sector
TAKE Solutions has announced a strategic integration of Anthropic’s Claude AI to enhance its healthcare technology stack. This move specifically targets the $370 billion healthcare sector by powering platforms like the 'One Minute Clinic' and a 'Unified AI Marketplace'. The initiative focuses on transitioning from reactive treatment to predictive and preventive care models using advanced clinical decision intelligence. By leveraging these AI capabilities, the company aims to improve operational efficiency and scale its services for global healthcare networks and pharmaceutical companies.
Key Highlights
Strategic integration of Anthropic's Claude AI to drive dominance in the $370B global healthcare market.
Enhancement of the 'One Minute Clinic' initiative for rapid health assessments and intelligent report generation.
Development of a Unified AI Marketplace for hospitals, diagnostic centers, and pharmaceutical providers.
Focus on predictive healthcare management to identify early health risks and enable proactive care.
💼 Action for Investors
Investors should view this as a significant technological upgrade that positions the company in the high-growth AI-healthcare segment. Monitor the company's upcoming quarterly results for signs of revenue traction from these newly enhanced AI platforms.
TAKE Solutions to Build Unified AI Platform for $370B Healthcare Ecosystem
TAKE Solutions has announced a strategic initiative to develop a Scalable Unified AI Platform, targeting India's $370 billion healthcare sector and a $197 billion preventive healthcare opportunity. The platform will act as a digital infrastructure layer and marketplace, enabling hospitals and labs to deploy AI for diagnostics, clinical trials, and hospital workflows. This move aligns with the IndiaAI Mission and positions the company to capture growth in the global AI healthcare market, which is projected to exceed $180 billion by 2030. The initiative marks a significant pivot toward high-growth digital health infrastructure.
Key Highlights
Developing a Unified AI Platform to address the $370 billion Indian healthcare ecosystem.
Targeting a $197 billion preventive healthcare opportunity through democratized AI access.
Platform to serve as a Healthcare AI Marketplace for diagnostics, clinical trials, and hospital workflows.
Strategic alignment with the IndiaAI Mission and the global AI healthcare market projected to surpass $180 billion by 2030.
💼 Action for Investors
Investors should monitor the company's ability to onboard healthcare providers and the subsequent impact on revenue growth from this digital platform. While the strategic direction is positive, execution and monetization within the competitive AI space will be critical factors to watch.
Take Solutions Reports Q3 Profit of ₹1.11 Cr; Auditors Raise Going Concern Doubts
Take Solutions reported a standalone net profit of ₹110.96 Lakhs for Q3 FY26, though this was driven entirely by other income as revenue from operations remained at zero. The company's auditors have issued a qualified opinion, highlighting material uncertainty regarding the firm's ability to continue as a going concern due to significant past losses and unpaid statutory dues. Management is currently exploring non-cash M&A opportunities to diversify operations following the divestment of its major subsidiary. Additionally, the board has rejected a promoter's request for reclassification to the public category citing procedural gaps.
Key Highlights
Revenue from operations stood at ₹0.00 for the quarter, with total income of ₹146.14 Lakhs derived from other sources.
Auditors flagged ₹883.2 Lakhs in tax assets and ₹516.4 Lakhs in indirect tax credits with uncertain recoverability.
Company faces contingent liabilities of ₹1,080.3 Lakhs related to direct tax litigations pending before various forums.
Net worth remains significantly impacted by a ₹6,973.60 Lakhs loss in the previous financial year following the Ecron Acunova divestment.
The Board declined Mr. Srinivasan HR's request to move from 'Promoter' to 'Public' category due to pending procedural requirements.
💼 Action for Investors
Investors should remain highly cautious as the auditor's 'going concern' warning and lack of operational revenue indicate extreme financial risk. The stock is speculative until the company successfully executes its proposed M&A strategy or restarts core business operations.
Take Solutions to Hold EOGM for Auditor Appointment and Office Shift to Maharashtra
Take Solutions Limited has scheduled an Extraordinary General Meeting (EOGM) for March 07, 2026, to seek shareholder approval for several significant corporate changes. Key resolutions include the appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors following the resignation of the previous auditors. The company also proposes shifting its registered office from Tamil Nadu to Maharashtra, which requires a special resolution. Additionally, shareholders will vote on the regularization of two Non-Executive Directors, Mr. Parmeshvar Dhangare and Mr. Vilas Munis.
Key Highlights
EOGM scheduled for March 07, 2026, to be held via Video Conferencing/Other Audio-Visual Means.
Proposed appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors to fill a casual vacancy.
Special resolution to shift the Registered Office from Chennai, Tamil Nadu, to the State of Maharashtra.
Regularization of Mr. Parmeshvar Dhangare and Mr. Vilas Munis as Non-Executive Non-Independent Directors.
Remote e-voting period is set from March 04 to March 06, 2026, with a cut-off date of February 28, 2026.
💼 Action for Investors
Investors should monitor the rationale behind the auditor's resignation and the strategic purpose of shifting the registered office to Maharashtra. Shareholders eligible as of February 28, 2026, should participate in the e-voting process to voice their stance on these governance changes.
Take Solutions to Shift Office to Maharashtra, Appoints New Auditor and Reviews Promoter Exit
Take Solutions has announced a major structural shift, moving its registered office from Tamil Nadu to Maharashtra. The board has appointed M/s. Venkat and Rangaa LLP as the new Statutory Auditor to fill a casual vacancy following the previous auditor's resignation. Crucially, the board is reviewing a request from promoter Mr. Srinivasan H R to be reclassified as a public shareholder, with a follow-up meeting scheduled for February 14, 2026. Additionally, the company is progressing with an AI-driven Diagnostic & Preventive Health Care Platform as part of its long-term strategy.
Key Highlights
Proposed shifting of registered office from Tamil Nadu to Maharashtra subject to shareholder approval.
Appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors following the resignation of M/s Sundar Srini & Sridhar.
Promoter Mr. Srinivasan H R has formally requested reclassification from 'Promoter' to 'Public' category.
Extra Ordinary General Meeting (EOGM) scheduled for March 7, 2026, for member approvals.
Board reviewed progress on an advanced AI-driven Diagnostic & Preventive Health Care Platform.
💼 Action for Investors
Investors should closely monitor the February 14 board meeting regarding the promoter's reclassification request, as this often signals a change in management control or potential exit. The change in statutory auditors also necessitates a review of the company's recent financial disclosures for any underlying issues.
Take Solutions to Shift Registered Office to Maharashtra and Appoints New Directors
Take Solutions has announced a significant shift of its registered office from Tamil Nadu to Maharashtra, subject to shareholder approval at an EOGM on March 7, 2026. The company is regularizing the appointment of M/s. Venkat and Rangaa LLP as statutory auditors following a casual vacancy. A key development is the request from promoter Mr. Srinivasan H R to be reclassified as a public shareholder, which the board will review on February 14, 2026. Additionally, the board reviewed the progress of a new AI-driven Diagnostic & Preventive Health Care Platform intended for long-term growth.
Key Highlights
Proposed shifting of registered office from Tamil Nadu to Maharashtra to align with corporate strategy.
Promoter Mr. Srinivasan H R has requested reclassification from 'Promoter' to 'Public' category.
Extra Ordinary General Meeting (EOGM) scheduled for March 7, 2026, for member approvals.
Appointment of Mr. Vilas Munis as Additional Non-Executive Non-Independent Director.
Regularization of M/s. Venkat and Rangaa LLP as Statutory Auditors following a previous resignation.
💼 Action for Investors
Investors should closely monitor the February 14 board meeting regarding the promoter's reclassification request, as this could signal changes in company control. The strategic pivot toward an AI-driven healthcare platform also requires long-term tracking for execution success.
Take Solutions Appoints New Director, Shifts Registered Office, and Reviews AI Platform
Take Solutions has announced a series of corporate changes, including the appointment of Mr. Vilas Munis as a Non-Executive Director and the shifting of its registered office from Tamil Nadu to Maharashtra. The company is also filling a statutory auditor vacancy following a resignation and has scheduled an EOGM for March 7, 2026, for shareholder approvals. Significantly, the board is reviewing a request from promoter Mr. Srinivasan H R to be reclassified as a public shareholder, with a decision expected on February 14, 2026. Additionally, the company is progressing with its long-term roadmap for an AI-driven Diagnostic & Preventive Health Care Platform.
Key Highlights
Appointment of Mr. Vilas Munis as Additional Non-Executive Director effective February 11, 2026.
Proposed shifting of the Registered Office from Tamil Nadu to Maharashtra subject to shareholder and MCA approval.
M/s. Venkat and Rangaa LLP appointed as Statutory Auditors to fill a casual vacancy caused by a resignation.
Promoter Mr. Srinivasan H R has requested reclassification to the 'Public' category, to be reviewed on February 14, 2026.
Extra Ordinary General Meeting (EOGM) scheduled for March 7, 2026, with e-voting starting March 4, 2026.
💼 Action for Investors
Investors should closely monitor the outcome of the February 14 board meeting regarding promoter reclassification and the reasons behind the auditor change. The shift in registered office and management changes suggest a significant corporate transition that requires a cautious approach.
Take Solutions to Shift Office to Maharashtra, Appoints New Directors and Reviews AI Platform
Take Solutions Limited has announced a series of significant governance and operational updates following its board meeting on February 11, 2026. Key decisions include shifting the registered office from Tamil Nadu to Maharashtra and the appointment of Mr. Vilas Munis as an Additional Director. The board also regularized the appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors to fill a casual vacancy. Furthermore, a request from promoter Mr. Srinivasan H R for reclassification to the 'Public' category was received, with a follow-up review scheduled for February 14, 2026.
Key Highlights
Proposed shifting of Registered Office from Tamil Nadu to Maharashtra, subject to shareholder and regulatory approval.
Appointment of Mr. Vilas Munis as Additional Non-Executive Non-Independent Director effective February 11, 2026.
Extraordinary General Meeting (EOGM) scheduled for March 7, 2026, to seek member approval for director and auditor appointments.
Board reviewed progress on a new AI-driven Diagnostic & Preventive Health Care Platform for long-term value creation.
Promoter Mr. Srinivasan H R has requested reclassification to the 'Public' category, to be examined on February 14, 2026.
💼 Action for Investors
Investors should closely monitor the outcome of the February 14 board meeting regarding the promoter's reclassification and the strategic progress of the AI healthcare platform. The shift in registered office and auditor changes suggest a period of internal restructuring that requires careful observation.
Take Solutions to Launch AI-Powered 'One Minute Clinic' for India's $197B Preventive Health Market
Take Solutions has announced a strategic expansion into the Indian preventive healthcare sector with the launch of 'One Minute Clinic,' AI-enabled smart diagnostic units. The initiative targets a market projected to reach USD 197 billion by 2030, aiming to provide affordable and accessible early health screenings. The company plans to import these integrated units from China to accelerate deployment across residential and public spaces. This move leverages the existing USD 13 billion Indian diagnostics industry to address high out-of-pocket healthcare expenses and rising lifestyle diseases.
Key Highlights
Targeting India's preventive healthcare market projected to reach USD 197 billion by 2030
Importing fully integrated AI-enabled smart health units from China for rapid nationwide deployment
Addressing a domestic diagnostics industry valued at USD 13 billion with double-digit growth potential
Focus on early detection for the 25% of adults with metabolic disorders and 1 in 4 at risk of heart disease
Strategy includes AI-driven diagnostics, instant digital health reports, and integrated teleconsultation pathways
💼 Action for Investors
Investors should monitor the company's rollout schedule and capital expenditure for these clinics to assess the impact on near-term margins versus long-term growth. The success of this pivot into digital health infrastructure could significantly re-rate the stock if scaling targets are met.
Take Solutions Appoints Venkat and Rangaa LLP as Statutory Auditor Following Resignation
Take Solutions Limited has appointed M/s. Venkat and Rangaa LLP as its new Statutory Auditor effective February 03, 2026. This appointment is intended to fill a casual vacancy created by the resignation of the previous auditor, M/s. Sundar Srini & Sridhar. The new firm, established in 1984, brings over 40 years of experience in audit, taxation, and advisory services. The appointment is subject to the final approval of the company's shareholders.
Key Highlights
Appointment of M/s. Venkat and Rangaa LLP (FRN: 004597S) effective from February 03, 2026
Fills casual vacancy caused by the resignation of previous auditors M/s. Sundar Srini & Sridhar
New auditing firm has over 40 years of experience in serving public sector banks and corporate clients
Board meeting approving the change concluded within 45 minutes on February 03, 2026
💼 Action for Investors
Investors should investigate the reasons behind the previous auditor's resignation to ensure there are no underlying governance or accounting issues. While the new firm is experienced, frequent auditor changes can be a signal for closer due diligence.
Take Solutions Appoints Venkat and Rangaa LLP as Statutory Auditors Following Resignation
Take Solutions Limited has appointed M/s. Venkat and Rangaa LLP as the new Statutory Auditors effective February 03, 2026. This appointment is intended to fill the casual vacancy created by the resignation of the previous auditors, M/s. Sundar Srini & Sridhar. The new auditing firm, established in 1984, brings over 40 years of experience in audit, taxation, and advisory services. The appointment is subject to the final approval of the company's shareholders.
Key Highlights
Appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors effective February 03, 2026
Fills casual vacancy caused by the resignation of M/s. Sundar Srini & Sridhar
New auditor firm has over 40 years of professional experience since its establishment in 1984
Board meeting concluded within 45 minutes, from 05:00 PM to 05:45 PM on February 03, 2026
💼 Action for Investors
Investors should monitor for any specific disclosures regarding the reasons for the previous auditor's resignation to ensure there are no underlying governance or accounting issues. The appointment of an experienced firm is a necessary step to maintain regulatory compliance.
Take Solutions CFO Vedamirtham Venkatesan and Director Cecily Dheepa Resign
Take Solutions Limited has announced the resignation of two key board members, including Mr. Vedamirtham Venkatesan, who served as the Chief Financial Officer and Whole Time Director. Additionally, Ms. Cecily Dheepa has stepped down from her role as a Non-Executive and Non-Independent Director. Both resignations are effective from December 31, 2025, with the stated reasons being personal commitments and pre-occupations. The simultaneous exit of the CFO and a director often warrants close monitoring of corporate governance and financial stability.
Key Highlights
Mr. Vedamirtham Venkatesan (DIN: 00194600) resigns as CFO and Whole Time Director effective Dec 31, 2025.
Ms. Cecily Dheepa (DIN: 07900799) resigns as Non-Executive Director effective Dec 31, 2025.
Both officials cited pre-occupations and personal commitments as the reason for their departure.
The company is now required to appoint a new CFO to ensure compliance with SEBI listing regulations.
💼 Action for Investors
Investors should monitor the company's upcoming announcements for the appointment of a new CFO. Sudden leadership changes in the finance department can sometimes precede operational shifts or reporting delays.
Take Solutions CFO Vedamirtham Venkatesan and Director Cecily Dheepa Resign
Take Solutions Limited has announced the resignation of its Chief Financial Officer and Whole Time Director, Mr. Vedamirtham Venkatesan, effective December 31, 2025. Simultaneously, Ms. Cecily Dheepa has stepped down from her role as a Non-Executive and Non-Independent Director. Both individuals cited personal commitments and pre-occupations as the reasons for their departure. The loss of a CFO is a significant event for a listed entity, as it can impact financial oversight and strategic continuity in the short term.
Key Highlights
Mr. Vedamirtham Venkatesan (DIN: 00194600) resigned as CFO and Whole Time Director effective Dec 31, 2025.
Ms. Cecily Dheepa (DIN: 07900799) resigned as Non-Executive and Non-Independent Director effective Dec 31, 2025.
Both resignations were effective immediately on the date of the announcement, December 31, 2025.
The company cited 'pre-occupations and other personal commitments' as the primary reason for both exits.
💼 Action for Investors
Investors should exercise caution and monitor the company's subsequent filings for the appointment of a new CFO to ensure financial governance remains stable. The sudden departure of key leadership often leads to short-term stock price volatility.
TAKE Solutions to Launch AI-Driven Diagnostic Platform Targeting USD 197Bn Market
TAKE Solutions has announced a strategic roadmap to develop an AI-powered Diagnostic & Preventive Care Platform, targeting India's preventive healthcare market which is projected to reach USD 197 billion by 2030. The initiative aims to capitalize on the USD 13 billion Indian diagnostics industry by offering early detection and predictive tools for chronic conditions. The platform will serve both clinical environments with AI-assisted decision tools and consumers with personalized health insights. This move represents a significant pivot towards high-growth, technology-led healthcare intelligence to drive long-term value.
Key Highlights
Targeting a preventive healthcare market projected to cross USD 197 billion by 2030.
Focusing on the Indian diagnostics industry currently valued at USD 13 billion with high growth potential.
Addressing critical health gaps where 25% of Indians show prediabetes signs and 1 in 4 are at risk of heart disease.
Leveraging India's base of 600+ million smartphone users for digital-first healthcare delivery.
Platform designed to provide AI-assisted clinical tools for doctors and real-time preventive care for households.
💼 Action for Investors
Investors should monitor the company's execution timeline and the specific capital expenditure required for this AI pivot. While the addressable market is large, the company's ability to compete with established diagnostic chains and tech-heavy health startups will determine its success.